Ganaxolone: ACMD Advice
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the classification of ganaxolone.
Ganaxolone is approved for marketing in the UK for the treatment of CDKL5, a rare epileptic seizure disorder. This letter provides advice on whether ganaxolone warrants control under the Misuse of Drugs Act 1971.
https://www.gov.uk/government/publications/ganaxolone-acmd-advice